Skip to main content

ScienceDex / Researcher record

Barouch, Dan H.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #11
  • Top 1% Funded
  • Rising Star
  • Long-Funded

NIH Funding · FY2023

$61.2M
Full award amounts, FY2023
4
Records listing this PI
#11
By linked amount among FY2023 PIs
2002
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2002$108,7291#28,518
2003$108,7291#30,425
2004$887,1653#5,317
2005$3,993,7954#404
2011$805,9271#8,923
2012$771,9511#9,395
2013$725,7441#9,570
2014$753,9321#9,572
2017$812,0771#8,997
2018$789,0651#10,273
2021$144,873,7873#7
2022$139,278,9279#6
2023$61,245,2954#11

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20021 record
  2. FY20031 record
  3. FY20043 records
  4. FY20054 records
  5. FY20111 record
  6. FY20121 record
  7. FY20131 record
  8. FY20141 record
  9. FY20171 record
  10. FY20181 record
  11. FY20213 records
  12. FY20229 records
  13. FY2023 · selected4 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Barouch, Dan H.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2023 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2002 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award records by amount

NIH award records listing Barouch, Dan H. as a PI. Multi-PI records show the full award amount for context.

  • 5UM1AI068614-18UM1Contact PI
    HIV Vaccines Clinical Trials Network Leadership and Operations Center
    $38.9M
    award amount
  • 3UM1AI068614-18S3UM1Contact PI
    CoVPN 3008 - Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern
    $19.4M
    award amount
  • 3UM1AI068614-18S1UM1Contact PI
    CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
    $2.7M
    award amount
  • 3UM1AI068614-18S2UM1Contact PI
    CoVPN 3001
    $305.3K
    award amount

Award organization

Organizations that administered FY2023 awards listing Barouch, Dan H. as a PI.

FY2023 award administered by Fred Hutchinson Cancer Center (WA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2002
    First NIH Award
    Fred Hutchinson Cancer Center
  2. 2004
    $500K Cumulative Funding
  3. 2004
    $1M Cumulative Funding
  4. 2004
    Entered Top 50% Nationally
    Ranked #5317
  5. 2005
    $2M Cumulative Funding
  6. 2005
    $5M Cumulative Funding
  7. 2005
    Entered Top 25% Nationally
    Ranked #404
  8. 2005
    Entered Top 10% Nationally
    Ranked #404
  9. 2005
    Entered Top 5% Nationally
    Ranked #404
  10. 2021
    $10M Cumulative Funding
  11. 2021
    $25M Cumulative Funding
  12. 2021
    $50M Cumulative Funding
  13. 2021
    $100M Cumulative Funding
  14. 2021
    Entered Top 1% Nationally
    Ranked #7